CLOSE X
GO

Nippon India Pharma Fund(G)

very highequitypharma & health care
487.11 1.15(0.24%) NAV as on 07 Apr 2026
-4.62 % 1 M
7 % 1 Y
20.97 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.81

As on 28 Feb, 2026
age-icon Age :

21 yrs 10 m

Since 05 06 ,2004
exit_load Exit Load :

1%

aum AUM :

8,306.35 Crs

lock_in Lock-in :

1% on or before 1M, Nil after 1M

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

7.56

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Sailesh Raj Bhan

LATEST ASSET & PORTFOLIO ALLOCATION

as on Feb 28 ,2026
Others 0.30 %
Equity 99.70 %

TOP HOLDINGS

Sun Pharmaceutical Industries...13.08 %
Lupin Ltd.7.99 %
Divi's Laboratories Ltd.6.56 %
Dr. Reddy's Laboratories Ltd.5.81 %
Cipla Ltd.5.67 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs74.41
Hospital & Healthcare Services20.63
Retailing3.70
Business Support0.96
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 31-Mar-2026)290.14270.59428.87481.27489.71
Net Assets(Rs Crores) (as on 31-Mar-2026) 4931.89 4304.46 7125.28 8080.97 8306.35
Scheme Returns(%)(Absolute)14.83-6.8558.2410.943.30
B'mark Returns(%)(Absolute)NANANANANA
Category Rank43/7565/7617/9030/10225/120

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Nippon India Pharma Fund(G)Very HighEquity487.111.15(0.24%)NAV As on 07 Apr, 202605-Jun-2004Inception Date8,306.35AUM In Cr.7.00%1Y20.97%3Y13.46%5Y19.46%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity36.69-0.01(-0.03%)NAV As on 07 Apr, 202613-Jul-2018Inception Date6,801.16AUM In Cr.6.69%1Y24.54%3Y15.50%5Y18.29%Since Inception
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity29.950.10(0.34%)NAV As on 07 Apr, 202610-Jul-2019Inception Date854.04AUM In Cr.7.42%1Y21.77%3Y12.51%5Y17.65%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors